c="bibliofondd_newuploads/2014-07/1406828854_Dieta-i-statiny-v-profilaktike-ishemicheskoiy-bolezni-serdca-literaturnyiy-obzor_1.gif" title="Дієта і статини у профілактиці ішемічної хвороби серця (літературний огляд)" alt="Дієта і статини у профілактиці ішемічної хвороби серця (літературний огляд)" width="624" height="250" />
Список літератури
1. Committee of Principal Investigators, WHO co-operative trail on primary prevention of ischemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up / / Lancet. 1980. Vol. 2. P. 379-385.
2. Lipid Research Clinics Programm. The Lipid Research Clinics Coronary Primary Prevention trial results. 1. Reduction in incidence of coronary heart disease / / JAMA. 1984. Vol. 251. P. 351-364.
3. Національні рекомендації з кардіоваскулярної профілактики / / Кардиоваскулярная терапія і профілактика. 2011. Т. 10. № 6. Дод. 2.
4. Guidelines EAS / ESC for the management of dislipidemias / / Eur. Heart. J. 2011. Vol. 32. P. 17-69.
5. Dietary Guidelines for Americans. 2010.
6. ЕганянР.А., ГамбарянМ.Г., ІзмайловаО.В. идр. Визначення груп здоров'я і вивчення аліментарно-залежних факторів ризику серцево-судинних захворювань в ході диспансерних оглядів / / Профілактична медицина. 2012. Т. 15. № 2. С.11-18.
7. Brief M., Ferreira-Gonzalez I., You J.J. et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis / / BMJ. 2009. Vol. 338. P. a3065; b92.
8. The long-term prevention with pravastatin in ischemic disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary Heart disease and a broad range of initial cholesterol levels / / N. Engl. J. Med. 1998. Vol. 339. P.1349-1357.
9. Downs J.R., Clearfield M., Weis S. et al. for the AF / TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels / / JAMA. 1998. Vol. 279. P. 1615-1622.
10. West of Scotland Coronary Prevention Study. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS) / / Circulation. 1998. Vol. 97. P. 1440-1445.
11. JUPITER Study group. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of lowdensitylipoprotein cholesterol and elevated high sensitivity. C-reactive protein: rationale and design of the JUPITER trial / / Circulation. 2003. Vol. 108. P. 2292-2297.
12. Ridker P.M., Danielson E., Fonseca F.A. et al. Rosuvastatin to prevent vascular events in men and woman with elevated C-reactive protein / / N. Engl. J. Med. 2008. Vol. 10. P. 1056.
13. Ridker P.M., MacFadyen J.G., Francisco D.F. et al. Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein. Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) / / Circ. Cardiovasc. Qual. Outcomes. 2009. Vol. 2. P. 616-623.
14. Sever P.S., Dahlof B., Poulter N.R. et al. For the ...
